Minimal residual disease in chronic myeloid leukemia
- PMID: 14534331
- DOI: 10.1056/NEJMp038130
Minimal residual disease in chronic myeloid leukemia
Comment on
-
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.N Engl J Med. 2003 Oct 9;349(15):1423-32. doi: 10.1056/NEJMoa030513. N Engl J Med. 2003. PMID: 14534335 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical